IPO: Glenmark Life Sciences.

COMPANY HISTORY

Glenmark Life Sciences (GLS) is founded in 2011. The company is a leading developer and manufacturer of Active Pharmaceutical Ingredients. GLS partners with the world's 16 of the top 20 generic companies & serves customers in multiple geographies including North America, Europe, Japan, Latin America and ROW.

Financials of The Company

Particulars	Years (amt in lakh)
	31/03/2021	31/03/2020	31/03/2019
Total Assets	19970.75	17256.04	14753.95
Total Revenue	18859.76	15493.03	8868.65
Profit After Tax	3515.81	3130.98	1955.92

Promoters' Holding:

After successful listing, promotors' Holding will be reduced form 100% to 82.84%.

IPO Details

IPO Opening Date	27-07-2021
IPO Closing Date	29-07-2021
IPO PRICE	Rs.695 to Rs.720 per equity share
Minimum Lot Size	20 Shares (1Lot)
Maximum Lot Size	260 Shares (13Lots)
Minimum Investment Amount	14400
Maximum Investment Amount	187200
Listing At	BSE, NSE
Issue Size	Equity Shares of Rs.2 (aggregating up to Rs.1513.6 Cr)
IPO Listing Date	06-08-2021

Grey Market Premium

GLS IPO grey market premium today is Rs.210.

My Recommendation

Every one should apply for this IPO.